Michael Gabriel

Summary

Affiliation: Innsbruck Medical University
Country: Austria

Publications

  1. ncbi 68Ga-DOTA-Tyr3-octreotide PET for assessing response to somatostatin-receptor-mediated radionuclide therapy
    Michael Gabriel
    Department of Nuclear Medicine, Innsbruck Medical University, Innsbruck, Austria and 2Department of Radiology, Innsbruck Medical University, Innsbruck, Austria
    J Nucl Med 50:1427-34. 2009
  2. ncbi 68Ga-DOTA-Tyr3-octreotide PET in neuroendocrine tumors: comparison with somatostatin receptor scintigraphy and CT
    Michael Gabriel
    Department of Nuclear Medicine, Innsbruck Medical University, Innsbruck, Austria
    J Nucl Med 48:508-18. 2007
  3. ncbi Individualized peptide-related-radionuclide-therapy concept using different radiolabelled somatostatin analogs in advanced cancer patients
    M Gabriel
    Department of Nuclear Medicine, Innsbruck Medical University, Innsbruck, Austria
    Q J Nucl Med Mol Imaging 54:92-9. 2010
  4. ncbi Virtual neck exploration: a new method for localizing abnormal parathyroid glands
    Rupert Prommegger
    Department of Operative Medicine, Innsbruck Medical University, Anichstrasse 35, A 6020 Innsbruck, Austria
    Ann Surg 250:761-5. 2009
  5. ncbi CT-MIBI-SPECT image fusion predicts multiglandular disease in hyperparathyroidism
    Gerd Wimmer
    Department of Operative Medicine, Medical University Innsbruck, Anichstrasse 35, 6020, Innsbruck, Austria
    Langenbecks Arch Surg 395:73-80. 2010
  6. ncbi Image fusion analysis of (99m)Tc-HYNIC-Tyr(3)-octreotide SPECT and diagnostic CT using an immobilisation device with external markers in patients with endocrine tumours
    Michael Gabriel
    Clinical Department of Nuclear Medicine, Innsbruck Medical University, Anichstrasse 35, 6020 Innsbruck, Austria
    Eur J Nucl Med Mol Imaging 32:1440-51. 2005
  7. ncbi Bone metastases in patients with neuroendocrine tumor: 68Ga-DOTA-Tyr3-octreotide PET in comparison to CT and bone scintigraphy
    Daniel Putzer
    Department of Nuclear Medicine, Innsbruck Medical University, Innsbruck, Austria
    J Nucl Med 50:1214-21. 2009
  8. ncbi Image fusion analysis of 99m Tc-HYNIC-octreotide scintigraphy and CT/MRI in patients with thyroid-associated orbitopathy: the importance of the lacrimal gland
    Hartmann Kainz
    Department of Nuclear Medicine, University Clinic, University of Innsbruck, Anichstrasse 35, 6020, Innsbruck, Austria
    Eur J Nucl Med Mol Imaging 30:1155-9. 2003
  9. ncbi Accuracy of preoperative pinhole subtraction single photon emission computed tomography for patients with primary and recurrent hyperparathyroidism in an endemic goiter area
    Christoph Profanter
    Department of General and Transplant Surgery, University of Innsbruck, Anichstrasse 35, A-6020, Innsbruck, Austria
    Surg Today 34:493-7. 2004
  10. ncbi Virtual neck exploration in patients with hyperparathyroidism and former cervical operations
    Gerd Wimmer
    Department of Visceral, Transplant and Thoracic Surgery, Center of Operative Medicine, Anichstrasse 35, 6020, Innsbruck, Austria
    Langenbecks Arch Surg 393:687-92. 2008

Detail Information

Publications28

  1. ncbi 68Ga-DOTA-Tyr3-octreotide PET for assessing response to somatostatin-receptor-mediated radionuclide therapy
    Michael Gabriel
    Department of Nuclear Medicine, Innsbruck Medical University, Innsbruck, Austria and 2Department of Radiology, Innsbruck Medical University, Innsbruck, Austria
    J Nucl Med 50:1427-34. 2009
    ..Our study compared (68)Ga-DOTA-TOC PET with CT or MRI using the Response Evaluation Criteria in Solid Tumors. Furthermore, standardized uptake values (SUVs) were calculated and compared with treatment outcome...
  2. ncbi 68Ga-DOTA-Tyr3-octreotide PET in neuroendocrine tumors: comparison with somatostatin receptor scintigraphy and CT
    Michael Gabriel
    Department of Nuclear Medicine, Innsbruck Medical University, Innsbruck, Austria
    J Nucl Med 48:508-18. 2007
    ..PET was compared with conventional scintigraphy and dedicated CT...
  3. ncbi Individualized peptide-related-radionuclide-therapy concept using different radiolabelled somatostatin analogs in advanced cancer patients
    M Gabriel
    Department of Nuclear Medicine, Innsbruck Medical University, Innsbruck, Austria
    Q J Nucl Med Mol Imaging 54:92-9. 2010
    ..This report presents data from the evaluation of the initial 100 patients receiving receptor mediated radionuclide therapy (PRRT) according to our protocol...
  4. ncbi Virtual neck exploration: a new method for localizing abnormal parathyroid glands
    Rupert Prommegger
    Department of Operative Medicine, Innsbruck Medical University, Anichstrasse 35, A 6020 Innsbruck, Austria
    Ann Surg 250:761-5. 2009
    ..The aim of this study was to evaluate whether CT-MIBI-SPECT image fusion is superior to MIBI-SPECT and CT in detecting abnormal parathyroid glands in patients with primary hyperparathyroidism...
  5. ncbi CT-MIBI-SPECT image fusion predicts multiglandular disease in hyperparathyroidism
    Gerd Wimmer
    Department of Operative Medicine, Medical University Innsbruck, Anichstrasse 35, 6020, Innsbruck, Austria
    Langenbecks Arch Surg 395:73-80. 2010
    ..The aim of this study was to evaluate whether CT-MIBI-SPECT image fusion is superior to MIBI-SPECT alone and CT alone in detecting abnormal parathyroid tissue in patients with multiglandular disease...
  6. ncbi Image fusion analysis of (99m)Tc-HYNIC-Tyr(3)-octreotide SPECT and diagnostic CT using an immobilisation device with external markers in patients with endocrine tumours
    Michael Gabriel
    Clinical Department of Nuclear Medicine, Innsbruck Medical University, Anichstrasse 35, 6020 Innsbruck, Austria
    Eur J Nucl Med Mol Imaging 32:1440-51. 2005
    ..The additional benefit derived from this methodological approach was analysed in comparison with SPECT and diagnostic CT alone in terms of detection rate, reliability and anatomical assignment of abnormal findings with SPECT...
  7. ncbi Bone metastases in patients with neuroendocrine tumor: 68Ga-DOTA-Tyr3-octreotide PET in comparison to CT and bone scintigraphy
    Daniel Putzer
    Department of Nuclear Medicine, Innsbruck Medical University, Innsbruck, Austria
    J Nucl Med 50:1214-21. 2009
    ..We compared the diagnostic value of CT with that of the novel somatostatin analog (68)Ga-1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-d-Phe(1)-Tyr(3)-octreotide ((68)Ga-DOTATOC) in the detection of such metastases...
  8. ncbi Image fusion analysis of 99m Tc-HYNIC-octreotide scintigraphy and CT/MRI in patients with thyroid-associated orbitopathy: the importance of the lacrimal gland
    Hartmann Kainz
    Department of Nuclear Medicine, University Clinic, University of Innsbruck, Anichstrasse 35, 6020, Innsbruck, Austria
    Eur J Nucl Med Mol Imaging 30:1155-9. 2003
    ..e. the lacrimal gland. The uptake of octreotide by lymphoid and salivary glands opens a new field of investigation related to the physiology of somatostatin...
  9. ncbi Accuracy of preoperative pinhole subtraction single photon emission computed tomography for patients with primary and recurrent hyperparathyroidism in an endemic goiter area
    Christoph Profanter
    Department of General and Transplant Surgery, University of Innsbruck, Anichstrasse 35, A-6020, Innsbruck, Austria
    Surg Today 34:493-7. 2004
    ..This may reduce the risk of surgical complications and expand the use of minimally invasive techniques in parathyroid surgery...
  10. ncbi Virtual neck exploration in patients with hyperparathyroidism and former cervical operations
    Gerd Wimmer
    Department of Visceral, Transplant and Thoracic Surgery, Center of Operative Medicine, Anichstrasse 35, 6020, Innsbruck, Austria
    Langenbecks Arch Surg 393:687-92. 2008
    ..The aim of this study was to evaluate whether CT-MIBI-SPECT image fusion is superior to MIBI-SPECT alone in detecting abnormal parathyroid glands in patients with previous neck surgery...
  11. ncbi 99mTc-EDDA/HYNIC-TOC and (18)F-FDG in thyroid cancer patients with negative (131)I whole-body scans
    Michael Gabriel
    Department of Nuclear Medicine, University of Innsbruck, Innsbruck, Austria
    Eur J Nucl Med Mol Imaging 31:330-41. 2004
    ....
  12. ncbi An intrapatient comparison of 99mTc-EDDA/HYNIC-TOC with 111In-DTPA-octreotide for diagnosis of somatostatin receptor-expressing tumors
    Michael Gabriel
    Department of Nuclear Medicine, University of Innsbruck, Innsbruck, Austria. Institute of Biostatistics, University of Innsbruck, Innsbruck, Austria. Nuclear Medicine Research Laboratory, St. Bartholomew's Hospital, London, United Kingdom
    J Nucl Med 44:708-16. 2003
    ..To avoid false-positive findings with (99m)Tc-OCT due to nonspecific tracer accumulation, additional scanning at 1-2 h after injection should be done...
  13. ncbi Functional imaging in phaeochromocytoma and neuroblastoma with 68Ga-DOTA-Tyr 3-octreotide positron emission tomography and 123I-metaiodobenzylguanidine
    Alexander Kroiss
    Department of Nuclear Medicine, Innsbruck Medical University, Anichstrasse 35, A 6020 Innsbruck, Austria
    Eur J Nucl Med Mol Imaging 38:865-73. 2011
    ....
  14. ncbi Procedure guidelines for PET/CT tumour imaging with 68Ga-DOTA-conjugated peptides: 68Ga-DOTA-TOC, 68Ga-DOTA-NOC, 68Ga-DOTA-TATE
    Irene Virgolini
    Medical University of Innsbruck, Innsbruck, Austria
    Eur J Nucl Med Mol Imaging 37:2004-10. 2010
    ..The same has been done with the relevant and recent literature in this field and the final result has been discussed by distinguished experts...
  15. ncbi Somatostatin receptor PET in neuroendocrine tumours: (68)Ga-DOTA (0),Tyr (3)-octreotide versus (68)Ga-DOTA (0)-lanreotide
    Daniel Putzer
    Department of Nuclear Medicine, Innsbruck Medical University, Anichstraße 35, 6020, Innsbruck, Austria
    Eur J Nucl Med Mol Imaging 40:364-72. 2013
    ....
  16. ncbi Concordance between results of somatostatin receptor scintigraphy with 111In-DOTA-DPhe 1-Tyr 3-octreotide and chromogranin A assay in patients with neuroendocrine tumours
    Margarida Rodrigues
    Department of Nuclear Medicine, Medical University of Innsbruck, Anichstrasse 35, 6020 Innsbruck, Austria
    Eur J Nucl Med Mol Imaging 35:1796-802. 2008
    ..Our aim was to compare directly in NET patients SRS and CgA assay results with special regard to tumour features such as grade of malignancy, primary origin, disease extent and function...
  17. ncbi Response of recurrent high-grade glioma to treatment with (90)Y-DOTATOC
    Dirk Heute
    Department of Nuclear Medicine, Medical University of Innsbruck, Innsbruck, Austria
    J Nucl Med 51:397-400. 2010
    ..We report the treatment of 3 patients who had World Health Organization grade IV recurrent glioblastoma: a 23-y-old woman and 2 men aged 61 and 62 y...
  18. ncbi 99mTc-N4-[Tyr3]Octreotate Versus 99mTc-EDDA/HYNIC-[Tyr3]Octreotide: an intrapatient comparison of two novel Technetium-99m labeled tracers for somatostatin receptor scintigraphy
    Michael Gabriel
    , Innsbruck, Austria
    Cancer Biother Radiopharm 19:73-9. 2004
    ..e. comparable uptake behavior in larger lesions with differences in smaller ones. 99mTc-Demotate is a promising agent for somatostatin receptor scintigraphy providing images of excellent quality as early as 1 hour after injection...
  19. ncbi Thyroid follicular carcinoma-like renal tumor: a case report with morphologic, immunophenotypic, cytogenetic, and scintigraphic studies
    William Sterlacci
    Department of Pathology, Medical University of Innsbruck, Muellerstr 44, Innsbruck, Austria
    Virchows Arch 452:91-5. 2008
    ..To our knowledge, this is the second fully documented case of a thyroid follicular carcinoma-like renal tumor. This uncommon variant is important to keep in mind to prevent unnecessary or inappropriate treatment...
  20. ncbi An individual dosimetric approach to 153Sm-EDTMP therapy for pain palliation in bone metastases in correlation with clinical results
    Dorota Kendler
    Department of Nuclear Medicine, University of Innsbruck, Austria
    Nucl Med Commun 25:367-73. 2004
    ..The clinical results of therapy using 153Sm ethylenediamine-N,N,N'N'-tetrakis(methylene phosphonic acid) (153Sm-EDTMP) were correlated with radiation dose indices in metastases, with the intention of improving the therapeutic efficacy...
  21. ncbi CT-MIBI image fusion: a new preoperative localization technique for primary, recurrent, and persistent hyperparathyroidism
    Christoph Profanter
    Department of General and Transplantation Surgery, Nuclear Medicine, University of Innsbruck, Innsbruck, Austria
    Surgery 135:157-62. 2004
    ..CT-MIBI image fusion can be performed on existing CT- and MIBI-SPECT units. We recommend this method for preoperative localization in patients with primary, recurrent and persistent hyperparathyroidism...
  22. ncbi 18FDG-PET for monitoring disease activity in an HIV-1 positive patient with disseminated chronic osteomyelitic brucellosis due to Brucella melitensis
    John J Zaknun
    University Clinic of Nuclear Medicine PET-Center, Anichstrasse 35, 6020, Innsbruck, Austria
    Eur J Nucl Med Mol Imaging 32:630. 2005
  23. ncbi Somatostatin receptor scintigraphy using (99m)Tc-EDDA/HYNIC-TOC in graves' disease
    Michael Gabriel
    Department of Nuclear Medicine, University of Innsbruck, Inichstrasse 35, 6020 Innsbruck, Austria
    Eur J Nucl Med Mol Imaging 29:1267. 2002
  24. ncbi Insular-type component follicular thyroid carcinoma in a 10-year-old girl--case report
    Rupert Prommegger
    Department of Paediatric and General Surgery, Innsbruck Medical School, A-6020 Innsbruck, Austria
    J Pediatr Surg 41:e5-7. 2006
    ..Prognosis concerning morbidity, pointing out the aspect of electrical neuromonitoring and precaution of parathyroid glands, and survival rate of this extremely rare entity are discussed...
  25. ncbi Her2/neu expression in poorly-differentiated and anaplastic thyroid carcinomas
    Christian Ensinger
    Institute of Pathology, University of Innsbruck, Muellerstr 44, A 6020 Innsbruck, Austria
    Anticancer Res 23:2349-53. 2003
    ..These findings suggest a decreasing impact of Her2/neu oncoproteins correlating to dedifferentiation, reflecting the aggressive biological behaviour of these tumors...
  26. ncbi Her2/neu expression in C-cell hyperplasia and medullary thyroid carcinomas
    Christian Ensinger
    Institute of Pathology, University of Innsbruck, Muellerstr 44, A 6020 Innsbruck, Austria
    Anticancer Res 23:2241-3. 2003
    ....
  27. ncbi 99mTc-Demotate 1: first data in tumour patients-results of a pilot/phase I study
    Clemens Decristoforo
    Univ Klinik fuer Nuklearmedizin, Anichstrasse 35, 6020 Innsbruck, Austria
    Eur J Nucl Med Mol Imaging 30:1211-9. 2003
    ..i.; some differences are observed in pharmacokinetic behaviour compared with (111)In-DTPA-octreotide...
  28. ncbi 99mTc-depreotide scintigraphy versus 18F-FDG-PET in the diagnosis of radioiodine-negative thyroid cancer
    Margarida Rodrigues
    University Clinic for Nuclear Medicine, Anichstrasse 35, A 6020 Innsbruck, Austria
    J Clin Endocrinol Metab 91:3997-4000. 2006
    ..Papillary and follicular thyroid cancer were found recently to express somatostatin receptors (SSTRs). (99m)Tc-depreotide binds with high affinity to SSTRs 2, 3, and 5...